prednisolone has been researched along with Late Onset Diseases in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, K | 1 |
| Hasegawa, K | 1 |
| Otsuka, F | 1 |
| Mylona, E | 1 |
| Vadala, C | 1 |
| Galanidi, E | 1 |
| Skliros, N | 1 |
| Loverdos, D | 1 |
| Skoutelis, A | 1 |
2 other studies available for prednisolone and Late Onset Diseases
| Article | Year |
|---|---|
Diffuse Vascular FDG Uptake in Late Onset Takayasu Arteritis.
Topics: Aged; Blood Sedimentation; C-Reactive Protein; Female; Fluorodeoxyglucose F18; Glucocorticoids; Huma | 2019 |
First Diagnosis of Systemic Lupus Erythematosus in a Patient on Hemodialysis for Hereditary Polycystic Renal Disease.
Topics: Aged; Female; Glucocorticoids; Humans; Kidney Failure, Chronic; Late Onset Disorders; Lupus Erythema | 2015 |